Press Releases by "Sumitomo Pharma Co., Ltd."

• Results of a Phase II Clinical Trial for Ranirestat - Therapeutic Agent for Diabetic Complications
  [ Pharmaceuticals | 2011-05-11]
• Dainippon Sumitomo Pharma announces Pan-Asia study results for lurasidone, an atypical antipsychotic agent, in the treatment of schizophrenia
  [ Pharmaceuticals | 2011-05-11]
• Change of Representative Directors
  [ Pharmaceuticals | 2011-05-11]
• Dainippon Sumitomo Pharma announces the launch of SUREPOST ,a rapid-acting insulin secretagogue
  [ Pharmaceuticals | 2011-05-09]
• Dainippon Sumitomo Pharma and Maruho Enter into a License Agreement for a Novel Topical Analgesic Drug
  [ Pharmaceuticals | 2011-04-27]
• CiRA and DSP Research the Creation of a New Treatment for Rare Intractable Diseases
  [ Pharmaceuticals | 2011-04-25]
• Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
  [ Pharmaceuticals | 2011-04-07]
• Impact of the Great East Japan Earthquake (Part 2)
  [ Pharmaceuticals | 2011-04-05]
• Dainippon Sumitomo Pharma Group Contributes to Earthquake Relief Efforts in Japan (Part 2)
  [ Pharmaceuticals | 2011-03-31]
• Revision of Financial Forecasts for the Year Ending March 31, 2011
  [ Pharmaceuticals | 2011-03-30]
• Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
  [ Pharmaceuticals | 2011-03-30]
• Takeda and DSP Sign Development, Manufacturing and Commercialization Agreement for a Cephem Antibiotic Ceftaroline in Japan
  [ Pharmaceuticals | 2011-03-30]
• DSP and Takeda Sign Development and Commercialization Agreement for an Atypical Antipsychotic Agent Lurasidone in Europe
  [ Pharmaceuticals | 2011-03-30]
• Dainippon Sumitomo Pharma Group Contributes to Earthquake Relief Efforts in Japan
  [ Pharmaceuticals | 2011-03-17]
• Impact of the Tohoku Earthquake
  [ Pharmaceuticals | 2011-03-17]
• Laboratory for Malignancy Control Research New cancer research facility in Kyoto University supported by Dainippon Sumitomo Pharma
  [ Pharmaceuticals | 2011-03-15]
• Dainippon Sumitomo Pharma Contributes to Earthquake Relief Efforts in Japan
  [ Pharmaceuticals | 2011-03-15]
• Approval obtained for partial change in dosage and administration of MEROPEN, a carbapenem antibiotic preparation
  [ Pharmaceuticals | 2011-03-10]
• Execution of the definitive agreement for the assignment of “Radarcirc”
  [ Pharmaceuticals | 2011-03-01]
• Execution of the definitive agreement for the assignment of “Radarcirc” business
  [ Pharmaceuticals | 2011-03-01]

Most Popular: "Sumitomo Pharma Co., Ltd."